J Mark FitzGerald Selected Research

3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)

1/2022	Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
10/2021	The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada.
1/2021	Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.
2/2019	Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study.
1/2019	Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada.
10/2017	The impact of inappropriate use of short acting beta agonists in asthma.
10/2017	The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Mark FitzGerald Research Topics

Disease

105	Asthma (Bronchial Asthma) 01/2022 - 11/2003
31	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2005
10	Inflammation (Inflammations) 12/2021 - 05/2014
4	Symptom Flare Up 01/2022 - 01/2022
4	Infections 01/2013 - 09/2008
3	Respiratory Sounds (Crackle) 09/2015 - 11/2009
3	Dyspnea (Shortness of Breath) 01/2013 - 10/2005
3	Tuberculosis (Tuberculoses) 09/2011 - 09/2005
2	Airway Remodeling 12/2020 - 01/2018
2	Fibrosis (Cirrhosis) 12/2020 - 02/2012
2	Latent Tuberculosis 01/2020 - 01/2013
2	Eosinophilia 01/2018 - 10/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 09/2009
1	Eczema 01/2021
1	Nasal Polyps (Nasal Polyp) 01/2021
1	Perennial Allergic Rhinitis 11/2020
1	Allergic Rhinitis 11/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Pulmonary Edema 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Adenoma (Adenomas) 01/2017
1	Pancytopenia 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Obstructive Lung Diseases (Obstructive Lung Disease) 11/2016
1	Nasopharyngitis 10/2016
1	Convalescence 01/2016
1	Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome 09/2015
1	Respiratory Hypersensitivity 05/2014

Drug/Important Bio-Agent (IBA)

50	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 11/2003
19	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 11/2003
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
15	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 11/2003
13	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 01/2005
11	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022 - 03/2017
11	benralizumabIBA 01/2022 - 10/2016
8	Terbutaline (Brethaire)FDA LinkGeneric 12/2021 - 01/2008
8	Monoclonal AntibodiesIBA 12/2020 - 10/2016
7	AllergensIBA 11/2020 - 11/2012
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 05/2014
6	Tiotropium Bromide (Spiriva)FDA Link 11/2020 - 01/2005
5	Muscarinic AntagonistsIBA 01/2022 - 11/2020
5	mepolizumabIBA 01/2022 - 09/2014
5	Formoterol Fumarate Drug Combination Budesonide FDA Link 12/2021 - 11/2003
5	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 12/2021 - 04/2012
5	Immunoglobulin E (IgE)IBA 10/2021 - 10/2016
5	GlucocorticoidsIBA 10/2021 - 09/2014
5	Interleukin-13IBA 12/2020 - 01/2017
4	Omalizumab (Xolair)FDA Link 01/2022 - 11/2015
4	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 01/2022
4	SteroidsIBA 01/2021 - 04/2005
4	Methacholine Chloride (Methacholine)FDA Link 01/2020 - 01/2018
4	Pharmaceutical PreparationsIBA 12/2019 - 11/2003
3	Biological ProductsIBA 01/2022 - 01/2017
3	dupilumabIBA 01/2022 - 01/2018
3	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2019 - 10/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 10/2005
3	Salmeterol Xinafoate (Serevent)FDA Link 09/2014 - 01/2005
2	reslizumabIBA 01/2022 - 12/2019
2	Interleukin-4 (Interleukin 4)IBA 11/2020 - 01/2017
2	InterleukinsIBA 11/2020 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020 - 01/2013
2	Prednisone (Sone)FDA LinkGeneric 08/2019 - 02/2013
2	GoldIBA 01/2019 - 11/2016
2	Interleukin-5 (Interleukin 5)IBA 07/2018 - 01/2017
2	C-Reactive ProteinIBA 01/2018 - 01/2017
2	CytokinesIBA 01/2017 - 05/2014
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 09/2014 - 01/2008
2	Fluticasone (Cutivate)FDA LinkGeneric 09/2014 - 04/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2009 - 06/2006
2	Oxygen (Dioxygen)IBA 07/2009 - 01/2007
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	NemiralisibIBA 01/2021
1	anti-IgE antibodiesIBA 01/2021
1	lebrikizumabIBA 12/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2019
1	antiarrhythmic peptide (AAP)IBA 10/2018
1	tralokinumabIBA 01/2018
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	PlacebosIBA 01/2018
1	Natriuretic PeptidesIBA 10/2017
1	PeriostinIBA 09/2017
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2016
1	ligelizumabIBA 10/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Thymic Stromal LymphopoietinIBA 05/2014
1	CarbonIBA 04/2013
1	A 7 (A-7)IBA 04/2013

Therapy/Procedure

53	Therapeutics 01/2022 - 11/2003
11	Nebulizers and Vaporizers (Inhaler) 11/2019 - 11/2003
6	Biological Therapy 01/2022 - 12/2021
3	Drug Therapy (Chemotherapy) 04/2021 - 10/2014
2	Ambulatory Care (Outpatient Care) 02/2016 - 09/2011
2	Bronchial Thermoplasty 01/2016 - 09/2015
1	Precision Medicine 01/2019
1	Inappropriate Prescribing 03/2017